Research ArticleClinical Studies
Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy
SERIKA MATSUOKA, HIRONORI FUJII, HIROTOSHI IIHARA, KOICHI OHATA, CHIEMI HIROSE, DAICHI WATANABE, SHIORI SADAKA, SHIGERU KIYAMA, AKITAKA MAKIYAMA, TAKAO TAKAHASHI, RYO KOBAYASHI, NOBUHISA MATSUHASHI and AKIO SUZUKI
Anticancer Research May 2023, 43 (5) 2351-2357; DOI: https://doi.org/10.21873/anticanres.16400
SERIKA MATSUOKA
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
HIRONORI FUJII
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
HIROTOSHI IIHARA
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
KOICHI OHATA
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
CHIEMI HIROSE
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
DAICHI WATANABE
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
SHIORI SADAKA
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
SHIGERU KIYAMA
2Department of Gastroenterological Surgery/Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan;
AKITAKA MAKIYAMA
2Department of Gastroenterological Surgery/Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan;
TAKAO TAKAHASHI
2Department of Gastroenterological Surgery/Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan;
RYO KOBAYASHI
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
3Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan
NOBUHISA MATSUHASHI
2Department of Gastroenterological Surgery/Pediatric Surgery, Gifu University Graduate School of Medicine, Gifu, Japan;
AKIO SUZUKI
1Department of Pharmacy, Gifu University Hospital, Gifu, Japan;
3Laboratory of Advanced Medical Pharmacy, Gifu Pharmaceutical University, Gifu, Japan
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
patientACCESS
patientACCESS - Patients desiring access to articles
In this issue
Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy
SERIKA MATSUOKA, HIRONORI FUJII, HIROTOSHI IIHARA, KOICHI OHATA, CHIEMI HIROSE, DAICHI WATANABE, SHIORI SADAKA, SHIGERU KIYAMA, AKITAKA MAKIYAMA, TAKAO TAKAHASHI, RYO KOBAYASHI, NOBUHISA MATSUHASHI, AKIO SUZUKI
Anticancer Research May 2023, 43 (5) 2351-2357; DOI: 10.21873/anticanres.16400
Emetogenicity and Risk Factors of Nausea and Vomiting in Patients With Metastatic Colorectal Cancer Receiving Trifluridine/Tipiracil and Bevacizumab Chemotherapy
SERIKA MATSUOKA, HIRONORI FUJII, HIROTOSHI IIHARA, KOICHI OHATA, CHIEMI HIROSE, DAICHI WATANABE, SHIORI SADAKA, SHIGERU KIYAMA, AKITAKA MAKIYAMA, TAKAO TAKAHASHI, RYO KOBAYASHI, NOBUHISA MATSUHASHI, AKIO SUZUKI
Anticancer Research May 2023, 43 (5) 2351-2357; DOI: 10.21873/anticanres.16400
Jump to section
Related Articles
- No related articles found.
Cited By...
- No citing articles found.